Antares Pharma Inc (ATRS.OQ)
ATRS.OQ on NASDAQ Stock Exchange Capital Market
3.53USD
16 Oct 2018
3.53USD
16 Oct 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$3.53
$3.53
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
237,320
237,320
52-wk High
$3.93
$3.93
52-wk Low
$1.59
$1.59
Revenue & Earnings Per Share
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 38.68 | 32.14 | |
| P/E High - Last 5 Yrs. | -- | 40.97 | 46.82 | |
| P/E Low - Last 5 Yrs. | -- | 24.76 | 24.71 | |
| Beta | 0.28 | 0.75 | 0.87 | |
| Price to Sales (TTM) | 295.44 | 6.95 | 6.55 | |
| Price to Book (MRQ) | -- | 5.90 | 4.00 | |
| Price to Tangible Book (MRQ) | -- | 12.35 | 6.10 | |
| Price to Cash Flow (TTM) | -- | 26.74 | 21.51 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.86 | 1.68 | |
| Dividend Yield - 5 Year Avg | -- | 1.10 | 1.45 | |
| Dividend 5 Year Growth Rate | -- | 16.89 | -5.91 | |
| Payout Ratio(TTM) | -- | 32.74 | 46.77 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -64.35 | 6.48 | 7.91 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -42.76 | 11.65 | 6.56 | |
| Sales - 5 Yr. Growth Rate | -5.00 | 9.90 | 7.49 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -54.02 | 0.01 | 26.63 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -28.03 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 15.39 | 7.65 | |
| Capital Spending - 5 Yr. Growth Rate | 36.90 | 6.85 | 8.16 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 0.14 | 2.23 | 2.22 |
| Current Ratio (MRQ) | 0.22 | 2.95 | 2.99 |
| LT Debt to Equity (MRQ) | -- | 23.93 | 11.31 |
| Total Debt to Equity (MRQ) | -- | 30.19 | 14.15 |
| Interest Coverage (TTM) | -149.72 | 19.10 | 34.46 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 17.36 | 58.50 | 54.36 | |
| Gross Margin - 5 Yr. Avg. | 50.95 | 57.97 | 53.16 | |
| EBITD Margin (TTM) | -153.74 | -- | -- | |
| EBITD - 5 Yr. Avg | -110.22 | 23.78 | 16.13 | |
| Operating Margin (TTM) | -244.46 | 19.29 | 3.36 | |
| Operating Margin - 5 Yr. Avg. | -131.86 | 16.25 | 11.28 | |
| Pre-Tax Margin (TTM) | -244.96 | 18.66 | 3.79 | |
| Pre-Tax Margin - 5 Yr. Avg. | -125.55 | 16.01 | 11.54 | |
| Net Profit Margin (TTM) | -244.96 | 14.70 | 0.60 | |
| Net Profit Margin - 5 Yr. Avg. | -125.55 | 11.21 | 7.83 | |
| Effective Tax Rate (TTM) | -- | 20.50 | 20.73 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 27.53 | 24.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 54,205 | 28,787,001 | 725,680,242 | |
| Net Income/Employee (TTM) | -132,778 | 3,553,574 | 84,001,075 | |
| Receivable Turnover (TTM) | 10.46 | 5.11 | 5.06 | |
| Inventory Turnover (TTM) | 3.58 | 3.14 | 3.65 | |
| Asset Turnover (TTM) | 0.80 | 0.77 | 0.82 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -195.99 | 10.81 | 9.83 | |
| Return on Assets - 5 Yr. Avg. | -60.29 | 9.30 | 10.94 | |
| Return on Investment (TTM) | -- | 13.89 | 12.83 | |
| Return on Investment - 5 Yr. Avg. | -76.85 | 12.07 | 14.05 | |
| Return on Equity (TTM) | -- | 16.74 | 14.95 | |
| Return on Equity - 5 Yr. Avg. | -79.39 | 14.70 | 15.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -42.76 | -18.76 | -5.00 |
| EPS (TTM) % | -28.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Antares Pharma Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.